QHP Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity
Stage Focus
Buyout, Growth Equity, Recapitalization, Growth
Geographical Focus
United States, Canada
Industries Focus
- Technology
- Healthcare
- Life Sciences
- Healthcare Services
- Medical Devices
- Diagnostics
- Biotechnology
- Health Services
- Medical Research
- Medical Equipment
- Health Technology
- Clinical Research
- Medical Technology
- Healthcare IT
- Biopharmaceuticals
- Healthcare Consulting
- Pharmaceutical Manufacturing
- Animal Health
- Pharmaceutical Services
- Contract Research Organizations
Investor Details Founded: 2010
QHP Capital, formerly known as NovaQuest Private Equity, is an operationally focused private equity firm investing in lower middle market healthcare companies primarily in North America. The firm partners with tech-enabled life sciences and pharmaceutical services companies that aim to reduce the total cost of care, fulfill unmet medical needs, diminish unnecessary procedures, improve efficiency, and elevate patient quality of life. QHP Capital invests in the form of buyouts, growth equity, and recapitalizations.
The firm's investment strategy focuses on services and technology companies within the healthcare and pharmaceutical services industries. QHP Capital leverages its extensive strategic network, including the affiliated fund strategy NovaQuest Product Finance, to source investments and drive revenue growth. The firm has a history of making platform and add-on acquisitions, with assets under management exceeding $1.9 billion. QHP Capital's partners have more than 30 years of middle market investing and operating experience.
QHP Capital's portfolio includes investments in companies such as CoreRx, Inc., a global contract development and manufacturing organization, and Pro-ficiency, LLC, a provider of tech-enabled training and compliance solutions for clinical trial investigators and site staff. The firm continues to focus on developing partnerships with companies at key inflection points, enhancing operations, and scaling the commercial efforts of these businesses.
Requirements
- Tech-enabled life sciences and pharmaceutical services companies
- Companies aiming to reduce total cost of care
- Businesses fulfilling unmet medical needs
- Firms focused on improving healthcare efficiency
- Companies enhancing patient quality of life
- Tech-enabled life sciences companies
- Pharmaceutical services companies
- Companies aiming to reduce healthcare costs
- Companies addressing unmet medical needs
- Companies improving patient quality of life
- Companies improving healthcare efficiency
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Azurity Pharmaceuticals
- Catalyst Clinical Research
- CoreRx
- Clinical Ink
- COPILOT Provider Support Services
- Pro-ficiency
- AutoCruitment
- Vector Clinical Trials
- CoreRx, Inc.
- Pro-ficiency, LLC
- Lexitas Pharma Services
Mentioned In
-
$24.95
-
$19.95
-
$14.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of QHP Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim